Details
Stereochemistry | ABSOLUTE |
Molecular Formula | 2C6H7O6.Mg |
Molecular Weight | 374.5374 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Mg++].[H][C@@]1(OC(=O)C(O)=C1[O-])[C@@H](O)CO.[H][C@@]2(OC(=O)C(O)=C2[O-])[C@@H](O)CO
InChI
InChIKey=AIOKQVJVNPDJKA-ZZMNMWMASA-L
InChI=1S/2C6H8O6.Mg/c2*7-1-2(8)5-3(9)4(10)6(11)12-5;/h2*2,5,7-10H,1H2;/q;;+2/p-2/t2*2-,5+;/m00./s1
DescriptionSources: DOI: 10.2903/j.efsa.2009.994Curator's Comment: description was created based on several sources, including:
http://www.xtend-life.com/information/ingredients/magnesium_ascorbate
Sources: DOI: 10.2903/j.efsa.2009.994
Curator's Comment: description was created based on several sources, including:
http://www.xtend-life.com/information/ingredients/magnesium_ascorbate
Magnesium ascorbate is a non-acidic buffered form of Vitamin C and a source of the essential mineral Magnesium. The in vitro model system consisted of the isolated section of rat small intestine. The sources of magnesium ion (Mg2+) were magnesium chloride, magnesium sulphate, magnesium acetate, magnesium lactate, magnesium hydrocitrate and magnesium ascorbate. Magnesium ions from magnesium ascorbate were absorbed after the first 15 minutes to the highest extent of all salts, but after 120 minutes their absorption was the smallest of all. The use of magnesium ascorbate in food supplements may lead to an additional exposure to vitamin C and Magnesium.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: WP1050 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16154915 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | Magnesium Ascorbate Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
[Magnesium ascorbate in anesthesiological practice; clinico-experimental study]. | 1955 Nov |
|
[CLINICAL RESEARCH ON THE SEPARATE AND COMBINED ACTION OF QUINIC ACID AND MAGNESIUM ASCORBATE IN 64 CASES OF HYPERAZOTEMIA]. | 1963 Jul-Aug |
|
Morphophysiological studies in experimental myocardial stress induced by isoproterenol. Note II. The myocardioprotector effect of magnesium ascorbate. | 1984 Jan-Mar |
|
Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics. | 2005 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.sourcenaturals.com/products/GP1414 DOI: 10.2903/j.efsa.2009.994
1 g twice daily (70 mg/magnesium/person/day)
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
2918 (Number of products:35)
Created by
admin on Thu Jul 06 01:49:49 UTC 2023 , Edited by admin on Thu Jul 06 01:49:49 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
0N1G678593
Created by
admin on Thu Jul 06 01:49:49 UTC 2023 , Edited by admin on Thu Jul 06 01:49:49 UTC 2023
|
PRIMARY | |||
|
239-442-6
Created by
admin on Thu Jul 06 01:49:49 UTC 2023 , Edited by admin on Thu Jul 06 01:49:49 UTC 2023
|
PRIMARY | |||
|
100000086176
Created by
admin on Thu Jul 06 01:49:49 UTC 2023 , Edited by admin on Thu Jul 06 01:49:49 UTC 2023
|
PRIMARY | |||
|
16211196
Created by
admin on Thu Jul 06 01:49:49 UTC 2023 , Edited by admin on Thu Jul 06 01:49:49 UTC 2023
|
PRIMARY | |||
|
DTXSID40165586
Created by
admin on Thu Jul 06 01:49:49 UTC 2023 , Edited by admin on Thu Jul 06 01:49:49 UTC 2023
|
PRIMARY | |||
|
DB14484
Created by
admin on Thu Jul 06 01:49:49 UTC 2023 , Edited by admin on Thu Jul 06 01:49:49 UTC 2023
|
PRIMARY | |||
|
137995-21-2
Created by
admin on Thu Jul 06 01:49:49 UTC 2023 , Edited by admin on Thu Jul 06 01:49:49 UTC 2023
|
NON-SPECIFIC STOICHIOMETRY | |||
|
0N1G678593
Created by
admin on Thu Jul 06 01:49:49 UTC 2023 , Edited by admin on Thu Jul 06 01:49:49 UTC 2023
|
PRIMARY | |||
|
1311396
Created by
admin on Thu Jul 06 01:49:49 UTC 2023 , Edited by admin on Thu Jul 06 01:49:49 UTC 2023
|
PRIMARY | RxNorm | ||
|
SUB03009MIG
Created by
admin on Thu Jul 06 01:49:49 UTC 2023 , Edited by admin on Thu Jul 06 01:49:49 UTC 2023
|
PRIMARY | |||
|
15431-40-0
Created by
admin on Thu Jul 06 01:49:49 UTC 2023 , Edited by admin on Thu Jul 06 01:49:49 UTC 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD